Skip to main content
Premium Trial:

Request an Annual Quote

Epigenomics Nearly Quadruples Sales in Q3

NEW YORK (GenomeWeb News) – Epigenomics yesterday reported that its third-quarter revenues bolted up over 250 percent and its net loss declined around 10 percent year over year.

The German molecular diagnostics firm reported total revenues of €1.2 million (US$1.8 million) over the three-month period ended Sept. 30, up from €320,000 for the third quarter of 2008.

Epigenomics' net loss for the third quarter fell to €2.3 million from €2.5 million.

The company's R&D costs fell 24 percent to €1.7 million from €2.1 million, while its sales, general, marketing, business development, and administrative costs were roughly even at €1.1 million.

The firm said that it plans to continue focusing its R&D activities on its colorectal, lung, and prostate cancer diagnostic pipeline.

Epigenomics finished the quarter with €7.2 million in cash and cash equivalents and €2.4 million in marketable securities.

The firm expects full-year revenue to be higher than 2008, with much of the increase coming from existing collaborations, new partnerships, and license agreements, as it expects to reach milestones in some of its partnerships in the fourth quarter.

Company CFO Oliver Schacht said in a statement that by the end of the third quarter the firm already hit its revenue goals for the fiscal year, with “significant progress” coming from its licensing partnerships.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.